Ikarian Capital, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$536,001
-25.1%
400,0000.0%0.06%
-43.9%
Q2 2023$716,000
-38.6%
400,000
+33.3%
0.11%
-57.0%
Q1 2023$1,167,000
+19350.0%
300,000
+36044.6%
0.26%
+26400.0%
Q1 2022$6,000
+20.0%
830
+5.7%
0.00%0.0%
Q4 2021$5,000
-44.4%
785
-0.8%
0.00%
Q1 2021$9,000
-25.0%
7910.0%0.00%
-100.0%
Q4 2020$12,000
-99.9%
791
-99.9%
0.00%
-99.9%
Q1 2020$11,300,000
+194.6%
588,222
+194.0%
0.85%
+36.7%
Q4 2019$3,836,000200,1000.62%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders